Advertisement

Uncategorized

BioMimetic Therapeutics' Phase III trial comparing its fully synthetic, off-the-shelf bone growth factor product, Augment Bone Graft, to autograft for use in hindfoot and ankle fusion surgery, has shown positive top-line results, according to a release from BioMimetic.

The Senate Finance Committee voted 14-9, with one republican vote from Sen. Olympia Snowe (R-Maine), to approve the committee's healthcare reform bill, according to a report by AHANews.

Advertisement
Advertisement